Hemostatic Bp Stand...

Hemostatic Bp Standard Tranexamic Acid CAS 1197-18-8

Hemostatic Bp Standard Tranexamic Acid CAS 1197-18-8

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity: >99%
  • Payment Terms : L/C,T/T,Other

Keywords

Tranexamic Acid 1197-18-8 trans-4-Aminomethylcyclohexane-1-carboxylate

Quick Details

  • Appearance:white Powder
  • Application:Organic intermediate
  • PackAge:1-5KG/Tin or Bag,25KG/Drum, 200KG/Drum
  • ProductionCapacity:1000 |Metric Ton|Year
  • Storage:Cool Dry Place
  • Transportation:by sea or by air

Superiority:

1)Quick Response Within 12 hours;
2)Quality Guarantee: All products are strictly tested by our QC, confirmed by QA and approved by third party lab in China, USA, Canada, Germany, UK, Italy, France etc.
3) OEM/ODM Available;
4) Reasonable & Competitive Price;
5) Fast Delivery: Samples from stock; bulk products within 7 days;
6) Professional Documents for Your Clearance;
7) Economic Freight Save Your Cost;
8) All your money be refund immediately if quality issue happens.

Details:

Product Details

Product Name
Tranexamic acid
Appearance
white powder
Assay by
HPLC
Mesh size
100% pass 80 mesh
Shelf life
2 years when properly stored
Package
drum and foil bag,or required by clients
Purity
99% Min, 99%


Tranexamic acid, also known as chloric acid, chemical name 4-aminomethyl cyclohexane formic acid, trade name Tosemin.Tranexamic acid (tranexamicacid) is a synthetic amino acid antifibrinolytic drug, which can competitively inhibit the binding of fibrin lysine to fibrinolytic enzyme, thus inhibit the cleavage of fibrin clot and produce hemostatic effect. it is mainly used in clinic for all kinds of bleeding caused by Chemicalbook caused by hyperfibrinolysis. Tranexamic acid is a synthetic lysine analogue, which can competitively bind the lysine binding site of plasminogen and plasmin, so as to competitively inhibit the degradation of fibrin, reduce the fibrinolytic activity and promote blood coagulation. In theory, the use of tranexamic acid can lead to insufficient fibrinolytic activity, so it is possible to increase the risk of postoperative thrombotic events.

Product Function

1.Tranexamic acid is mainly used for various types of bleeding caused by acute or chronic, localized or systemic fibrinolysis.

2. The melamine-removing effect of tranexamic acid is about 50 times higher than vitamin C and nearly 10 times that of fruit acid, so it can also be used for skin whitening.

3. Pay attention to the secondary high fibrinolysis state caused by disseminated intravascular coagulation, and use this product with caution before heparinization.

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View